1017579-80-4

Basic information

• Product Name: N-(4-(3-ethynylphenoxy)butyl)-1,5-dideoxy-1,5-imino-D-glucitol
• Synonyms: N-(4-(3-ethynylphenoxy)butyl)-1,5-dideoxy-1,5-imino-D-glucitol
• CAS NO: 1017579-80-4
• Molecular Weight: 335.4
• Mol File: 1017579-80-4.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: N-(4-(3-ethynylphenoxy)butyl)-1,5-dideoxy-1,5-imino-D-glucitol(CAS DataBase Reference)
• NIST Chemistry Reference: N-(4-(3-ethynylphenoxy)butyl)-1,5-dideoxy-1,5-imino-D-glucitol(1017579-80-4)
• EPA Substance Registry System: N-(4-(3-ethynylphenoxy)butyl)-1,5-dideoxy-1,5-imino-D-glucitol(1017579-80-4)

Safety Data

• Hazardous Substances Data: 1017579-80-4(Hazardous Substances Data)

Upstream product

• 19130-96-2 1,5-dideoxy-1,5-imino-D-glucitol 
• 1017579-77-9 1-ethynyl-3-(4-iodobutoxy)benzene 

Downstream Products

• 1017579-83-7 N-(4-(3-ethynylphenoxy)butyl)-2,3,4,6-tetra-O-acetyl-1,5-dideoxy-1,5-imino-D-glucitol 

Relevant articles and documents

Hybrid angiogenesis inhibitors: Synthesis and biological evaluation of bifunctional compounds based on 1-deoxynojirimycin and aryl-1,2,3-triazoles

Synthesis of hybrids of 1-deoxynojirimycin (DNJ) and 5-aryl-1,2,3-triazole as potential bifunctional inhibitors of angiogenesis is described. The DNJ component inhibits the biosynthesis of cell surface oligosaccharides necessary for angiogenesis, whereas the aryl-1,2,3-triazole inhibits methionine aminopeptidase II, a target in angiogenesis therapy. One bifunctional compound was a more potent inhibitor of angiogenesis in vitro than DNJ alone or the 5-aryl-1,2,3-triazole alone.